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Abstract
Background: There have been repeated initiatives to produce standard nosologies and terminologies for
cutaneous disease, some dedicated to the domain and some part of bigger terminologies such as ICD-10. Recently,
formally structured terminologies, ontologies, have been widely developed in many areas of biomedical research.
Primarily, these address the aim of providing comprehensive working terminologies for domains of knowledge, but
because of the knowledge contained in the relationships between terms they can also be used computationally for
many purposes.
Results: We have developed an ontology of cutaneous disease, constructed manually by domain experts. With
more than 3000 terms, DermO represents the most comprehensive formal dermatological disease terminology
available. The disease entities are categorized in 20 upper level terms, which use a variety of features such as
anatomical location, heritability, affected cell or tissue type, or etiology, as the features for classification, in line with
professional practice and nosology in dermatology. Available in OBO flatfile and OWL 2 formats, it is integrated
semantically with other ontologies and terminologies describing diseases and phenotypes. We demonstrate the
application of DermO to text mining the biomedical literature and in the creation of a network describing the
phenotypic relationships between cutaneous diseases.
Conclusions: DermO is an ontology with broad coverage of the domain of dermatologic disease and we
demonstrate here its utility for text mining and investigation of phenotypic relationships between dermatologic
disorders. We envision that in the future it may be applied to the creation and mining of electronic health records,
clinical training and basic research, as it supports automated inference and reasoning, and for the broader
integration of skin disease information with that from other domains.
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Background
Estimation of the impact of skin disease on population
morbidity and mortality has always been complicated by
the nature of the terminologies used for recording dis-
ease incidence, prevalence and cause of death. However
measured, it remains a highly significant social, eco-
nomic and clinical burden. In the USA, collective preva-
lence estimates for skin disease are greater than those of
obesity, hypertension and cancer [1]. There have been
repeated initiatives to generate structured terminologies
of sufficient granularity to accurately capture skin dis-
ease diagnoses, but the available tools, such as ICD-10,
remain blunt instruments in the face of the pressing
need for precision phenotyping, and are unsuitable for
many types of computation-based research. We have,
with the close involvement of domain experts in derma-
tology, pathology, and genetics, consequently created a
new ontology, DermO, for cutaneous disease.
There have been several previous initiatives to devise
lexicons or structured comprehensive terminologies for
the description of cutaneous disorders, for example the
Dermatologischer Diagnosenkatalog [2]. The most recent
is the DermLex ontology [3, 4], created under the auspices
of the American Academy of Dermatology, with the pur-
pose of providing a definitive nomenclature for clinical
dermatology [5]. This terminology was merged with the
British Association of Dermatologist’s BAD Index and is
mapped to International Classification of Disease (ICD9-
CM) codes. However, maintenance of DermLex was dis-
continued in 2009. This lexicon covered sporadic and
inherited cutaneous disorders and consisted of 6104 terms
including a nosology, classic signs, therapeutic procedures,
and anatomical distributions. To date DermLex has been
the most comprehensive tool for capturing dermatological
disease information. The Human Disease Ontology (DO)
[6] also contains an integumentary branch of 234 terms,
with skin and adnexal diseases classified as skin, hair, and
nail disease. Likewise, the Human Phenotype Ontology
(HPO) [7] contains a branch of skin and adnexal pheno-
types with terms focused on phenotypic manifestations of
cutaneous disorders. Skin diseases are largely out of the
scope of HPO, which primarily focuses on phenotypes
and does not aim to cover the breadth of cutaneous condi-
tions we envisage. Similarly, the DO’s coverage and
organization of the integumentary branch is limited and
may not entirely capture the breadth and diversity of cuta-
neous conditions required for the purposes of patient
stratification, population analysis, cross-species compari-
sons, database query expansion and automated reasoning.
The current revision of ICD, ICD-11, will contain the
most radical revision of dermatology terms since 1948
and so far around 2000 terms have been assigned to the
dermatology chapter (XII) with 20 major subdivisions
[8]. ICD-11 is not currently finalized (June 2016) and
uptake is expected to be gradual (for example the USA
has only recently transitioned to ICD-10 for electronic
health records as of 1.10.15) [9].
The other main resource for dermatological disease
terms is SNOMED-CT. Whilst SNOMED contains
more than 2000 terms related to cutaneous disease the
coverage and structure of the terminology does not
lend itself to detailed clinical description and having a
relatively flat hierarchy does not permit the relation-
ships between diseases to be used computationally in
a useful way. (Discussed in [4]). An additional issue
remains the licensing of SNOMED-CT by the Inter-
national Health Terminology Standards Development
Organization (IHTSDO) that precludes its free use in
some countries.
The main applications for DermO are data capture
and informatic analyses that only recently have become
feasible using electronic health records, and semantic
integration of disease information between species and
across domains of knowledge; these analyses require a
sufficiently rich structure, granularity, and coverage
from the available terminologies. We have therefore cre-
ated a new ontology from the scientific literature with the
close involvement of domain experts in dermatology,
pathology, and genetics, while explicitly maintaining inter-
operability with established ontologies and vocabularies in
the biomedical domain, DermO is organized in a manner
intuitive to dermatologists and dermatopathologists. The
framework adopted for the development of DermO was
based on that of the definitive clinical dermatology text,
Dermatology by Bolognia et al. [10]. The specific aim is to
include all of the currently accepted primary and second-
ary skin diseases, including those caused by systemic dis-
orders, external insult, and the genodermatoses. DermO
was developed with the intention of creating a tool applic-
able to patient care, clinical training and basic research, as
well as to support automated inference and reasoning. It
can be used for patient stratification, genotype/phenotype
studies, and for the broader integration of skin dis-
ease information with that from other domains, such
as model organism phenotypes and pharmacogenomics
for translational science. DermO is freely available on
https://github.com/dermatology-ontology/dermatology.
Methods
Ontology construction
DermO was constructed by domain experts using the
framework of the most recent definitive text on Derma-
tology edited by Bolognia et al. [10]. The approach taken
was to produce a classification familiar to dermatologists,
as the envisaged uses of DermO include both patient diag-
nostic annotations by clinicians and mining of electronic
health records. The formalization of patient information
provides a data resource that can be expanded to integrate
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historical and newly generated information from both
human and mouse dermatology, and genetic studies.
The structure adopted for DermO is familiar both for
diagnostic support and patient data recording purposes.
Because of the inclusion of systemic and inherited dis-
eases, DermO also includes diseases that would normally
be found in other branches of a disease ontology, such
as Mendelian monogenic syndromes, and for completeness
we therefore use a degree of polyhierarchy and include
genetic diseases (the genodermatoses) as well as systemic
diseases. For the same reasons the ICD-11 topic advisory
group adopted a similar approach [11].
The ontology was manually constructed using OBO-Edit
[12] and the OWL2 version prepared using Protégé [13].
Consistency was verified using the HermiT reasoner [14],
which detected no inconsistencies and no unsatisfiable
classes, mainly due to the absence of disjointness axioms
in the ontology. The main ontology is available in both the
OBO Flatfile format [15] and the Web Ontology Language
(OWL) [16]. DermO is housed in a Github repository and
is made available via Bioportal (permanent URL: http://
purl.bioontology.org/ontology/DERMO) [17], Aber-OWL
(permanent URL: http://aber-owl.net/ontology/DERMO)
and on the project’s website https://github.com/dermatol-
ogy-ontology/dermatology.
Content, relations and mapping to other ontologies
DermO was constructed as a simple ontology with limited
polyhierarchy, and currently contains 3,425 classes (Fig. 1,
Table 1). These are currently mapped to concepts in other
major terminologies and provided with synonyms (Table 2).
Synonyms were sourced from Bolognia et al. [10],
DermnetNZ [18] and from expert curator knowledge.
Class labels and synonyms were initially lexically mapped
to concepts in UMLS [19], ICD-10, MPO [20], HPO [7],
DO [6], OMIM (Online Mendelian Inheritance in Man)
[21], SNOMED-CT [22], Medical Subject Headings
(MeSH) and DermLex [4]. Only exact mappings were in-
cluded and are provided as cross-references in the ontol-
ogy. All were all manually verified. We also provide textual
definitions for some of the diseases in DermO; creating
further definitions is an ongoing process that has been
greatly helped by participation of the Dermnet NZ [18].
The majority of relations used to structure DermO
are is-a relations. Where appropriate, the results-in
and has-symptom relations are also used to indicate
where a disease develops as a sequel to another or
where a disease is characterized by specific manifestations
that might also occur in isolation. This latter relationship
might also be viewed as that between a disease and pheno-
type as discussed below.
Design considerations
Integration of the widest possible range of disease con-
cepts into DermO brought with it challenges also seen in
other phenotype and disease ontologies, such as DO and
HPO which are dealt with in different ways, if indeed they
are systematically addressed at all. The strategy we took
was to allow multiple axes of classification, requiring
polyhierarchy and resulting in a greatly increased richness.
There are particular design considerations with the
genodermatoses and etiologically predicated sub-types
Fig. 1 Part of the DermO ontology. The ontology classifies cutaneous diseases by etiology, anatomical location/cell type, and phenotype
consistent with current clinical practice, and uses polyhierarchy (multiple parents) to maximize the types of knowledge captured by the ontology.
The figure shows the path up the hierarchy for the classification of, neutrophilic cicatricial alopecia, with parent terms outlined in red and with a
red arrow connecting parents and children. Multiple types of classification allow for multiple entry points and views of diseases. For example
Psoriasis is a child of “papulosquamous disorder”, “inflammatory dermatoses”, and “causes of secondary erythroderma”. Most of the relations shown
here are “is_a” – ie the child is a “type-of” its parent. Note that not all of the terms in this region of the ontology are shown here, for clarity
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of disease. Our solutions and reasoning may be helpful to
other developers of phenotypic and disease ontologies.
Genodermatoses
The definition of a genodermatosis varies between
terminologies [23] but broadly refers to inherited genetic
skin conditions, often part of phenotypically diverse
syndromes, and including mono-, polygenic, and chromo-
somal lesions. Probably the most comprehensive recent
attempt to classify these is from Feramisco et al. [24, 25]
who produced a database of genodermatoses derived from
OMIM. They used manually curated phenotype terms to
define the skin phenotypes of these genodermatoses to
generate a phenotypic map of these diseases in order to
discover novel relationships. We included most of the
genodermatoses captured by Feramisco et al. into DermO,
and also have added those considered by other studies,
leading to a total of 537 genodermatoses in DermO. Fur-
thermore, we have included subtypes of genodermatoses
in phenotypic series and variants that did not receive their
own OMIM identifier as separate manifestations rather
than adopting the strategy of collapsing all the variants
into a broad disease. For example, hidradenitis suppura-
tiva (DOID: 2280) includes three subtypes of a phenotypic
series (OMIM: 142690, OMIM: 613736, OMIM: 613737),
all of which have a distinct phenotype and genetic etiology
(NCSTN, PSENN, and PSEN1 respectively). To facilitate
studies of molecular mechanisms using DermO, such
as classification in pathway analyses, patient population
stratification, or identification of drugs for diseases in
which each subtype may have different therapeutic in-
dications, we separate the three sub-types of hidrade-
nitis suppurativa into individual diseases. There are
other cases where disease subtypes have no separate
OMIM identifiers. For example, in the case of Darier-
White disease (OMIM: 124200) we identify 11 subtypes.
Only two are recognized in OMIM, “segmental” and
“acral-hemorrhagic”, and neither have independent identi-
fiers. No subtypes are listed for this disease in the geno-
dermatosis database of Feramisco et al. We identify all of
these as separate diseases in DermO so that their different
etiology can be taken into account in data analysis.
Etiologically predicated disease subtypes
Parallel classification of diseases by etiology allows for dis-
crimination between the actions of different agents, which,
although leading to the same outcome, may do so by differ-
ent pathogenetic mechanisms – often termed “phenocopy”.
In cases where this is well established, such as psoriasis
[26], we have created subclasses of diseases based on the
etiologic (causative or exacerbating) agent, such as virus,
bacterium, or physical trauma, with the aim of being able
to capture potentially important information for patient
stratification and genotype/phenotype association. Such dis-
ease classes then have subclass relationships to classes that
structure dermatological diseases based on their etiology.
For example, fungal skin disease (DERMO:00002246)
is a parent of “psoriasis triggered by fungal infection”
(DERMO:0000004) [26], which has as its second parent
“psoriasis” (DERMO:0000124). This enables identification
of all the fungal skin diseases (including psoriasis triggered
Table 1 Upper level classes of the DermO ontology
Class
Cutaneous
disease
Adnexal disease
Anogenital non-venereal disease
Atrophy or disorder of dermal connective tissue
Developmental anomaly
Disorder caused by infections, infestations stings or bites
Disorder due to physical agent
Disorder of hair or nails
Disorder of Langerhans cells or macrophages
Disorder of neoplasm of the skin
Disorders of subcutaneous fat
Genodermatosis
Metabolic or systemic disease
Oral disorder
Papulosquamous or eczematous dermatosis
Pigmentary disorder
Pruritis, dysaesthesia or psychocutaneous disorder
Rheumatological disorder
Urticaria, erythema or purpura
Vascular disorder
Vesiculobullous disease
The root class is cutaneous disease (DERMO:0000001) with 20 sibling child
classes describing the head levels of the axes of classification and include
etiology, anatomical location and inheritance, conforming to recognized
criteria for classification of dermatological diseases from Bolognia et al. [10]
Table 2 Cross-ontology mapping of DermO classes
Ontology Number of cross-referenced classes
Disease Ontology 1330
Human Phenotype Ontology 373
MeSH thesaurus 1509
UMLS 1398
ICD-10 537
DermLex 1054
SNOMED-CT 2337
Unreferenced classes 1773
Dermo classes were lexically mapped to a set of related ontologies and
mappings subsequently manually checked. Only exact mappings were
included but in many cases one DermO term could be mapped to classes in
multiple ontologies with the same label or synonym. About half the classes in
DermO have no match in the ontologies examined. Mappings are included in
the ontology as cross references
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by fungal infection), or, using the other parent, identifying
all the inflammatory dermatoses.
Literature mining and network construction
Literature mining and construction of a phenotypic re-
latedness network for DermO classes was carried out as
previously reported by us for the DO [27], and full
methods may be found in this paper. In brief, the Aber-
OWL: Pubmed infrastructure was used to semantically
mine Medline abstracts. Aber-OWL: Pubmed (http://
aber-owl.net/aber-owl/pubmed/) consists of an ontology
repository, a reasoning infrastructure providing OWL-
EL reasoning over the ontologies in the repository, a full
text index of all Medline 2014 titles and abstracts as well
as all Pubmed Central articles, and a search interface as
described in Hoehndorf et al. [27]. Documents were
dealt with as a title and abstract and filtered by presence
of at least one term from a phenotype ontology (MP or
HPO) and one term from DermO. The resulting indexed
corpus consisted of 781,000 documents.
Statistically significant co-occurrences of disease and
phenotype terms were identified using Normalized
Pointwise Mutual Information (NPMI) [28] with the aim
of associating HPO and MPO classes with individual
concepts from DermO.
These phenotypes can be freely accessed on http://
aber-owl.net/aber-owl/dermophenotypes/ (Fig. 2). [29]
Phenomenet is then used to establish the phenotypic
relatedness of DermO classes in order to generate a net-
work and visualised using a force directed layout using the
Gephi graph visualization tool [30]. The algorithm for
establishing relatedness is fully described in [27].
Results and Discussion
Scope and structure of DermO
Diseases of the skin and its adnexa fall mainly into three
major categories which are well recognized by dermatol-
ogists; disease originating in the skin (sporadically or in
response to external insults) with mainly cutaneous mani-
festations (I), diseases of the skin resulting from systemic
disease such as metabolic or endocrine disorders (II), and
heritable or genetic disease where skin manifestations are
part of a syndrome (III) and may either arise independently
of other aspects of the syndrome, or as a secondary
Fig. 2 The Aber-Owl dermatological disease web page (http://aber-owl.net/aber-owl/dermophenotypes/) allows users to select a disease from
the drop down box (view 1) and then retrieve a list of terms form the human or mammalian phenotype ontologies that are associated with it in
the literature (view 2). The prioritization of these associations is determined by various metrics described in Hoehndorf et al, [27]. Users are able to
reorder depending on the metric they wish to use. Each association can then be related to the Pubmed papers and abstracts that gave rise to it
by clicking on the “search” link on the right hand side of the page (view 3)
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consequence. The nature of cutaneous diseases, as with
other anatomically classified diseases, include hyperplastic,
dysplastic, neoplastic, and degenerative disorders for ex-
ample, but many disease entities include manifestations of
several of these pathological processes. This complexity
consequently provides problems in how to logically classify
the diseases.
DermO aims to capture knowledge about the domain
of human cutaneous disorders in the form of a directed
acyclic graph. It does not contain information about de-
vices, procedures, diagnostic measurements or patient
management. The ontological definition of diseases as dis-
positions rooted in physical disorders, realized through
pathological processes, as proposed by Scheuermann et al.
[31], is consistent with the criteria used for inclusion in
DermO and all are children of the root term “cutaneous
disease”. However the distinction between “phenotypes”
and “diseases” is less clear; an issue with most attempts to
capture the clinical domain. For example “atopic derma-
titis” (DERMO:0000122) occurs sporadically and in isola-
tion, and is regarded as a cutaneous disease, but also
occurs as part of more complex syndromes such as mental
retardation, obesity, mandibular prognathism with eye and
skin anomalies [32] (MOMES syndrome) (OMIM: 606772)
and consequently is treated as a disease in DO (DOID:3310
“atopic dermatitis”) and a phenotype in HPO (HP:0000964
“atopic dermatitis”). We feel that in such cases the
distinction between “disease” and “phenotype” is largely
dependent on context and have consequently included all
that may be regarded as clinical disease entities, as opposed
to clinical phenotype observations, as part of DermO, with
cross-references to other ontologies where they also occur.
The disease entities in DermO are categorized in 20
upper level terms which use a variety of features such as
anatomical location, heritability, affected cell or tissue type
or etiology, as the features for classification, in line with
professional practice and nosology in dermatology (Fig. 1,
Table 1). The maximal depth is 11, and the majority of ax-
ioms used to structure DermO use is-a relations. 1,330
terms are common to DermO and DO and 373 are com-
mon to HPO, 152 to the Mammalian Phenotype Ontology
(MPO), 1509 to the Medical Subject Headings (MeSH)
thesaurus [33], 1398 to the Unified Medical Language Sys-
tem (UMLS), 537 to ICD-10, and 1054 to DermLex. 1203
classes in DermO map to 2337 classes in SNOMED-CT
(RF2 release; USA, September 2015) (see Table 2). About
half the classes could not be mapped to any of the above
terminologies (1773), while many were mapped to more
than one terminology, indicating significant redundancy
of classes within the set of ontologies we used.
Using DermO to mine the biomedical literature
There currently exists no high quality comprehensive
phenotypic description of complex and common
dermatological diseases. Using the approach we pio-
neered to harvest phenotypic descriptions of common
disease from the scientific literature we have applied the
same methodology using the coverage and resolution
provided by DermO. The results of this analysis provide
a rich resource of the associated phenotypes for dermato-
logical diseases, including symptoms and co-morbidities.
Using these descriptions to establish the phenotypic
relatedness of the disease concepts in DermO we can
generate a similarity network that provides insights
into the mechanistic and pathobiological nature of
these entities. It also a provides a novel and objective
axis of classification, different to that traditionally
used in dermatology, with the potential for providing
novel insights into the pathobiology.
The area of the network shown in Fig. 3 contains several
well-defined clusters of disease entity (in square frames):
the dermatides; a cluster of epidermolytic dermatoses and
keratoses; and a cluster of diseases of the eyelid, grouped
by anatomy. Inclusion of some diseases within these clus-
ters may at first sight be counter-intuitive, or at least
counter-canonical. However when considering that the
criteria for classification of diseases together in this case is
purely phenotypic, they provide useful insights into the re-
lationship between multiple disease entities. For example
the inclusion of neurotic excoriation (DERMO:0000179)
with the dermatitis cluster reflects the hair pulling and
skin picking phenotypes associated with almost all types
of dermatitis, shown here qualified by both etiology and
pathological process. Clustering of several epidermolytic
and keratotic diseases in the second cluster is interesting
from the point of view of frequent co-occurrence in the
same syndromic disease entities. These diseases are not
usually included in the same group within standard ter-
minologies, but clustering here reflects an underlying
pathoetiological mechanism in some patients where
disruption to epithelial junctions in the bullous diseases
is often associated with hyperkeratosis and disruption
of the dermal-epidermal junction. For example poro-
and hyper- keratosis are seen together with bullous
pathology in syndromic skin diseases such as the epi-
dermolytic hyperkeratoses, and keratosis follicularis
(Darier disease, (DERMO:0000064)) can present in bul-
lous form [34]. Similarly palmoplantar keratoderma
(palmoplantar keratosis), (DERMO:0000049) is also re-
ported associated with blistering [35] reflecting an
autoimmune origin of both phenotypes. The approach
therefore enriches the pathobiological profile of well-
established diseases and in some cases our mining of
the literature highlights significant associations, some-
times in subsets of patients, that are often overlooked.
An excellent example of this is the phenotypic de-
scription of Non-Herlitz type junctional epidermolysis
bullosa (NHJEB), located in a neighbouring cluster
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(data from http://aber-owl.net/aber-owl/dermophenotypes/),
where the text-mined phenotypes indicate a link with
nail dystrophy. The Lamc2 mouse, considered to be a
model of NHJEB, does not show the nail phenotype
flagged by our mining of the literature, which is rela-
tively rare in humans, but introduction of a variant in a
second locus, Col17α1, modified the disease to include
the nail phenotype and model the subclass of human
disease more accurately. This approach is now being
followed for other dermatological diseases in the
search for modifiers of canonical conditions using
model organisms [Sproule TJ, Sundberg JP, Low BE,
Silva KA, Reyon D, Joung JK, Wiles MV, Roopenian
DC. TALEN-induced nested deletions and sequence
replacements of collagen 17a1 reveal the functional
basis of a genetic modifier of junctional epidermolysis
bullosa in mice. PLos Genetics (submitted)].
The text-mined phenotypes are now integrated into
Phenomenet [36] which allows for exploration of exist-
ing mouse models using the richer phenotypic descrip-
tions of the skin diseases we provide. This supports
disease gene discovery, where the gene (s) underlying a
disease in humans is (are) unknown, and translational
research. Such descriptions have not previously been
available for common and complex skin disease.
Conclusions
DermO was conceived as a formal ontology and structured
terminology to describe human cutaneous diseases. DermO
can be used as a tool in patient care, clinical training and
basic research. The provision of disease relationships and
groupings which have pathobiological and etiological sig-
nificance based on phenotype makes DermO valuable for
using automated inference and reasoning as well as in data
mining applications, but we envisage wider applicability,
from precision phenotyping of patients, through differential
diagnosis, to the discovery of new physiological and patho-
physiological pathways and integration of human and
model organism phenotype data.
DermO can be used to extract data from patient elec-
tronic health records using text mining, or to translate
existing variable-granularity coding such as ICD-10 to
allow capture and standardization of patient/disease
annotations. For example ICD-10 has 19 sub- types of
bullous disorder including Not Otherwise Specified (NOS),
whereas, excluding the bullous diseases of the newborn,
DermO contains 84. Using the structure of the ontology
patients may be grouped or split at different levels of
granularity which will enable the fine-tuning of both
Genome Wide Association Studies (GWAS) and Phenome
Wide Association Studies (PheWAS) [37, 38] analysis.
Fig. 3 Clustering of skin diseases on the basis of phenotype similarity. The phenotypic profiles of each disease in DermO are related to each
other through the phenotype ontologies and the strength of the association reflected in the presence and length of the lines connecting them.
The algorithm for this is described in detail in Hoehndorf et al. [27]. This example shows close clustering of three types of skin disease, carried out
automatically on the basis of the spectrum of text-mined phenotypes. This network is based on phenotype/disease associations established using
NPMI [28] with phenotypic similarity determined using Phenomenet [36]
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This will facilitate both the discovery of new genetic
variation underlying skin diseases and the establishment
of unexpected skin and other phenotypes associated
with established genetic variants in and around genes
identified as important through hypothesis-driven research.
An additional advantage of this approach is the potential
to identify other variation-associated predisposed pheno-
types which might not have been noted previously, and
which may shed light on the pathobiology of the disease
through the introduction of novel and objective axes of
classification by phenotype. In the future, we envision
integrating DermO with the integumentary disease
branch of the DO so that the deep and broad coverage
of dermatological diseases we provide in DermO can be
used in conjunction with other diseases within the DO.
DermO, as with other open ontologies, is owned by the
community that uses it and so we encourage users to
participate in its development and improvement through
the project website.
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